32 Gardenia Pty. Limited

Status: Registered
Australian Company Number: 097262596
Australian Business Number: 87097262596
Registration date: 2001-06-25
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


32 Gardenia Pty Limited is a limited by shares Australian proprietary company. Located at VIC 3130 since 2010-05-01 the company is, as the updated on 2010-07-30 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2010-07-29. Known company numbers for 32 Gardenia Pty Limited are as follows: ACN - 097262596, Australian Business Number - 87097262596. Anne Dalton & Associates is one of the trading names this company has used, to be precise, the trading names list includes 1 position that is Anne Dalton & Associates since 2010-05-01. We found 0 trademarks that reference this company.


Details for ABN 87097262596

Type: Australian Private Company

ABN Status

Status From To
Active 2010-05-01 current

Main Name

Name From To
32 Gardenia Pty. Limited 2010-05-01 current

Trading Names

Name From To
Anne Dalton & Associates 2010-05-01 current

Main Location

Location From To
VIC 3130 2010-05-01 current

Goods & Services Tax (GST)

Status From To
Registered 2010-07-29 current


Find company

VIC 3130 Location

2016 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.